A combination of computed tomography scan and ultrasound provides optimal detection of cervical lymph node metastasis in papillary thyroid carcinomas: A systematic review and meta-analysis
- PMID: 37417426
- DOI: 10.1002/hed.27451
A combination of computed tomography scan and ultrasound provides optimal detection of cervical lymph node metastasis in papillary thyroid carcinomas: A systematic review and meta-analysis
Abstract
Background: Lymph node metastasis (LNM) in patients with papillary thyroid carcinoma (PTC) is common. This meta-analysis assesses the diagnostic accuracy of computed tomography (CT), ultrasound (US), and CT + US in detecting central and lateral LNM.
Methods: A systematic review and meta-analysis was performed by searching PubMed, Embase, and Cochrane for studies published up to April 2022. The pooled sensitivity, specificity, and diagnostic odds ratio (DOR) were calculated. The area under the curve (AUC) for summary receiver operating curves (sROC) were compared.
Results: The study population included 7902 patients with a total of 15 014 lymph nodes. Twenty-four studies analyzed the sensitivity of the overall neck region in which dual CT + US imaging (55.9%) had greater sensitivities (p < 0.001) than either US (48.4%) or CT (50.4%) alone. The specificity of US alone (89.0%) was greater (p < 0.001) than CT alone (88.5%) or dual imaging (86.8%). The DOR for dual CT + US imaging was greatest (p < 0.001) at 11.134, while the AUCs of the three imaging modalities were similar (p > 0.05). Twenty-one studies analyzed the sensitivity of the central neck region in which both CT (45.8%) and CT + US imaging (43.4%) had greater sensitivities (p < 0.001) than US alone (35.3%). The specificity of all three modalities was higher than 85%. The DOR for CT (7.985) was greater than US alone (4.723, p < 0.001) or dual CT + US imaging (4.907, p = 0.015). The AUC of both CT + US (0.785) and CT alone (0.785) were significantly greater (p < 0.001) than US alone (0.685). Of the 19 studies that reported lateral LNM, CT + US imaging sensitivity (84.5%) was higher than CT alone (69.2%, p < 0.001) and US alone (79.7%, p = 0.038). The specificity of all imaging techniques was all greater than 80.0%. CT + US imaging DOR (35.573) was greater than CT (20.959, p = 0.024) and US (15.181, p < 0.001) individually. The AUC of independent imaging was high (CT: 0.863, US: 0.858) and improved significantly when combined (CT + US: 0.919, p = 0.024 and p < 0.001, respectively).
Conclusions: We report an up-to-date analysis elucidating the diagnostic accuracy of LNM detection by either CT, US, or in combination. Our work suggests dual CT + US to be the best for overall detection of LNM and CT to be preferable in detecting central LNM. The use of either CT or US alone may detect lateral LNM with acceptable accuracy, yet dual imaging (CT + US) significantly improved detection rates.
Keywords: computed tomography; lymph node metastasis; meta-analysis; papillary thyroid carcinoma; ultrasound.
© 2023 Wiley Periodicals LLC.
Similar articles
-
Thyroid cancer neck lymph nodes metastasis: Meta-analysis of US and CT diagnosis.Eur J Radiol. 2020 Aug;129:109103. doi: 10.1016/j.ejrad.2020.109103. Epub 2020 Jun 13. Eur J Radiol. 2020. PMID: 32574937
-
Diagnostic accuracy of ultrasound, CT and their combination in detecting cervical lymph node metastasis in patients with papillary thyroid cancer: a systematic review and meta-analysis.BMJ Open. 2022 Jul 4;12(7):e051568. doi: 10.1136/bmjopen-2021-051568. BMJ Open. 2022. PMID: 35788082 Free PMC article.
-
Quantitative analysis of dual-phase enhanced CT in cervical lymph node metastasis of papillary thyroid carcinoma: a comparative study along with pathological manifestations.Endocrine. 2023 Oct;82(1):108-116. doi: 10.1007/s12020-023-03386-8. Epub 2023 May 6. Endocrine. 2023. PMID: 37148418
-
Clinical value of dual-energy CT for predicting occult metastasis in central neck lymph nodes of papillary thyroid carcinoma.Eur Radiol. 2024 Jan;34(1):16-25. doi: 10.1007/s00330-023-10004-8. Epub 2023 Aug 1. Eur Radiol. 2024. PMID: 37526667
-
Diagnostic performance of dual-energy computed tomography (DECT) quantitative parameters for detecting metastatic cervical lymph nodes in patients with papillary thyroid cancer: A systematic review and meta-analysis.Eur J Radiol. 2025 Feb;183:111917. doi: 10.1016/j.ejrad.2025.111917. Epub 2025 Jan 3. Eur J Radiol. 2025. PMID: 39778378
Cited by
-
Diagnostic performance of contrast-enhanced ultrasound vs. conventional ultrasound for lymph node metastasis in patients with thyroid cancer: A meta-analysis.Oncol Lett. 2025 Jun 24;30(3):407. doi: 10.3892/ol.2025.15153. eCollection 2025 Sep. Oncol Lett. 2025. PMID: 40613033 Free PMC article.
-
Precision of predictive nomograms for lymph node metastasis of thyroid cancer from Chinese real-world study: a systematic review and meta-analysis.Front Endocrinol (Lausanne). 2025 Jul 9;16:1617563. doi: 10.3389/fendo.2025.1617563. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40704150 Free PMC article.
-
The Oncologic Outcomes of Bilateral Central Lymph Node Dissection in Unilobar Papillary Thyroid Cancer and Its Risks: A Prospective Cohort Study.Cureus. 2024 Jul 26;16(7):e65443. doi: 10.7759/cureus.65443. eCollection 2024 Jul. Cureus. 2024. PMID: 39184776 Free PMC article.
-
Role of computed tomography in the evaluation of regional metastasis in well-differentiated thyroid cancer.Front Radiol. 2023 Oct 31;3:1243000. doi: 10.3389/fradi.2023.1243000. eCollection 2023. Front Radiol. 2023. PMID: 38022790 Free PMC article.
-
The diagnosis and management of small and indeterminate lymph nodes in papillary thyroid cancer: preoperatively and intraoperatively.Front Endocrinol (Lausanne). 2024 Nov 14;15:1484838. doi: 10.3389/fendo.2024.1484838. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39610843 Free PMC article. Review.
References
REFERENCES
-
- Ze Y, Zhang X, Shao F, et al. Active surveillance of low-risk papillary thyroid carcinoma: a promising strategy requiring additional evidence. J Cancer Res Clin Oncol. 2019;145:2751-2759. doi:10.1007/s00432-019-03021-y
-
- Powers AE, Marcadis AR, Lee M, Morris LGT, Marti JL. Changes in trends in thyroid cancer incidence in the United States, 1992 to 2016. JAMA. 2019;322:2440-2441. doi:10.1001/jama.2019.18528
-
- Rossi ED, Pantanowitz L, Hornick JL. A worldwide journey of thyroid cancer incidence centred on tumour histology. Lancet Diabetes Endocrinol. 2021;9:193-194. doi:10.1016/s2213-8587(21)00049-8
-
- Haddad RI, Nasr C, Bischoff L, et al. NCCN guidelines insights: thyroid carcinoma, version 2.2018. J Natl Compr Canc Netw. 2018;16:1429-1440. doi:10.6004/jnccn.2018.0089
-
- Diker-Cohen T, Hirsch D, Shimon I, et al. Impact of minimal extrathyroid extension in differentiated thyroid cancer: systematic review and meta-analysis. J Clin Endocrinol Metabol. 2018;103:2100-2106. doi:10.1210/jc.2018-00081
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous